Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Avalyn Pharma Inc. (AVLN) Institutional Ownership & Insider Trading

92 institutions reported holding Avalyn Pharma Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 4 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · read by EquiReason

AVLNAvalyn Pharma Inc.Follow AVLN — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
16 Nov, in 23 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

92 institutions held 99.3% of the shares. Across filers that reported both quarters, shares held changed —.

Increased+0New+0Decreased+0Closed+0

Largest moves, shares (millions)

Avalyn Pharma Inc. — questions

Who owns Avalyn Pharma Inc. stock?
92 institutions reported Avalyn Pharma Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (13.2%), NOVO HOLDINGS A/S (8.8%), SR One Capital Management, LP (7.5%).
Are Avalyn Pharma Inc. insiders buying or selling?
4 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Avalyn Pharma Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.